www.feizichem.com    Shijiazhuang FeiZi Chemical Technology Co., Ltd

At the mid-year summary meeting held on July 14, 2025, the company announced its operational performance for the first half of the year: sales performance increased by 21% compared to the same period last year.

During the mid-year meeting, the Chairman stated that although the 21% sales growth fell short of the target, it was a commendable achievement given the current economic climate. This success was primarily driven by three key breakthroughs: the R&D department significantly reduced product costs through process innovation, the sales department expanded the customer base by 5% by leveraging emerging channels, and the production department improved workforce efficiency by 9% through lean management.

Looking ahead to the second half of the year, the company announced the launch of the "Innovation-Driven" initiative under the current economic conditions:

R&D Upgrade: An additional 5 million yuan in special R&D funding will be allocated to focus on breaking through core technical bottlenecks.

Mechanism Innovation: A 500,000 yuan innovation incentive fund will be established, implementing a closed-loop mechanism of "employee proposals—expert evaluation—rapid implementation."

Talent Development: Top 20% of key employees will be provided with paid further education and industry exchange opportunities.

The General Manager emphasized: "The 21% growth curve was built on breakthroughs in every position. Now, we must solidify this breakthrough capability as part of the company's DNA."

Our company's products include

2,3-Dimethyl-4-Nitropyridine N-Oxide CAS： 37699-43-7

Mycolide    CAS： 14289-65-7

Sandenol CAS： 3407-42-9

Methyl 2-(methylamino)benzoate      CAS： 85-91-6

1-phenylethyl propionate     CAS： 120-45-6